메뉴 건너뛰기




Volumn 15, Issue 5, 2013, Pages 1016-1019

A highly convergent and efficient synthesis of a macrocyclic hepatitis C virus protease inhibitor BI 201302

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84874628035     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol303498m     Document Type: Article
Times cited : (34)

References (29)
  • 3
    • 84874583618 scopus 로고    scopus 로고
    • Boceprevir/Victrelis was approved by US FDA on May 13th
    • Boceprevir/Victrelis was approved by US FDA on May 13th 2011.
    • (2011)
  • 4
    • 84874606028 scopus 로고    scopus 로고
    • Telaprevir/Incivek was approved by US FDA on May 23rd
    • Telaprevir/Incivek was approved by US FDA on May 23rd 2011.
    • (2011)
  • 7
    • 84874598882 scopus 로고    scopus 로고
    • Int. Appl. WO 2004089974
    • Dersch, W.; Samstag, W. Int. Appl. WO 2004089974 (2004).
    • (2004)
    • Dersch, W.1    Samstag, W.2
  • 10
    • 84874588377 scopus 로고    scopus 로고
    • PCT Int. Appl. WO 2007030656
    • Shu, C. (2007). PCT Int. Appl. WO 2007030656.
    • (2007)
    • Shu, C.1
  • 12
    • 16844366046 scopus 로고    scopus 로고
    • Change of initiation site is known to affect RCM. See
    • Change of initiation site is known to affect RCM. See: Wallace, D. Angew. Chem., Int. Ed. 2005, 44, 1912-1915
    • (2005) Angew. Chem., Int. Ed. , vol.44 , pp. 1912-1915
    • Wallace, D.1
  • 14
    • 84874616554 scopus 로고    scopus 로고
    • Jaguar, v 6.5; Schrödinger, Inc. New York
    • Jaguar, v 6.5; Schrödinger, Inc.: New York, 2006.
    • (2006)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.